Crescent Capital BDC, Inc. Reports December 31, 2022 Financial Results; Declares a First Quarter 2023 Regular Dividend of $0.41 per Share

Rhea-AI Summary

Crescent Capital BDC (NASDAQ: CCAP) reported a net investment income of $59.7 million or $1.93 per share for 2022, alongside an adjusted net investment income of $53.4 million or $1.73 per share. The fourth quarter net investment income was $16.1 million, $0.52 per share, maintaining the quarterly dividend at $0.41 per share for Q1 2023, payable on April 17. As of December 31, 2022, net asset value per share was $19.83. The company invested $308 million in 2022, a decline from $647.4 million in 2021, with total expenses rising to $57 million due to increased debt costs.

Positive

• Net investment income rose to $59.7 million in 2022 from $47.6 million in 2021.
• Quarterly dividend maintained at $0.41 per share.

Negative

• Total expenses increased to $57 million in 2022, up from $46.4 million in 2021.
• Significant decline in investments to $308 million in 2022 compared to $647.4 million in 2021.
• Net asset value per share fell from $21.12 in 2021 to $19.83 in 2022.

LOS ANGELES, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $59.7 million, or $1.93 per share, and adjusted net investment income of $53.4 million, or $1.73 per share, for the year ended December 31, 2022. For the quarter ended December 31, 2022, net investment income was $16.1 million, or $0.52 per share, and adjusted net investment income was $15.0 million, or $0.49 per share.¹ Reported net asset value per share was $19.83 at December 31, 2022.

The Company announced that its Board of Directors declared a regular cash dividend for the first quarter of 2023 of $0.41 per share, which will be paid on April 17, 2023 to stockholders of record as of the close of business on March 31, 2023.

Selected Financial Highlights
($ in millions, except per share amounts)

		As of and for the three months ended
		December 31, 2022					September 30, 2022					December 31, 2021
Investments, at fair value		$		1,263.0			$		1,292.9			$		1,270.4
Total assets		$		1,302.9			$		1,339.3			$		1,317.8
Total net assets		$		612.5			$		622.6			$		652.3
Net asset value per share		$		19.83			$		20.16			$		21.12
Investment income		$		34.6			$		29.0			$		24.1
Net investment income		$		16.1			$		16.0			$		12.5
Net realized gains (losses), net of taxes		$		(0.0	)		$		(2.5	)		$		(0.4	)
Net change in unrealized gains (losses), net of taxes		$		(13.5	)		$		(15.8	)		$		0.7
Net increase (decrease) in net assets resulting from operations		$		2.6			$		(2.4	)		$		12.8
Net investment income per share		$		0.52			$		0.52			$		0.42
Net realized gains (losses) per share, net of taxes		$		(0.00	)		$		(0.08	)		$		(0.01	)
Net change in unrealized gains (losses) per share, net of taxes		$		(0.44	)		$		(0.51	)		$		0.02
Net increase (decrease) in net assets resulting from operations per share		$		0.08			$		(0.08	)		$		0.44
Regular distributions paid per share		$		0.41			$		0.41			$		0.41
Special distributions paid per share				—			$		0.05			$		0.05
Non-GAAP Financial Measures1:
Adjusted net investment income		$		15.0			$		13.0			$		12.7
Adjusted net investment income per share		$		0.49			$		0.42			$		0.43
Weighted average yield on income producing securities (at cost)2				10.8	%				9.5	%				7.5	%
Percentage of debt investments at floating rates				98.8	%				98.7	%				98.5	%

Portfolio & Investment Activity

As of December 31, 2022 and 2021, the Company had investments in 129 and 134 portfolio companies with an aggregate fair value of $1,263.0 and $1,270.4 million, respectively. The portfolio at fair value was comprised of the following asset types:

Portfolio Asset Types:
		As of December 31,
$ in millions		2022										2021
Investment Type		Fair Value					Percentage					Fair Value					Percentage
Senior secured first lien		$		301.0				23.8		%		$		329.9				26.0		%
Unitranche first lien3				824.1				65.2						731.0				57.5
Unitranche first lien - last out3				13.8				1.1						13.7				1.1
Senior secured second lien				60.9				4.8						72.7				5.7
Unsecured debt				4.5				0.4						5.6				0.4
Equity & other				44.9				3.6						59.5				4.7
LLC/LP equity interests				13.8				1.1						58.0				4.6
Total investments		$		1,263.0				100.0		%		$		1,270.4				100.0		%

Full Year

For the year ended December 31, 2022, the Company invested $308.0 million across 20 new portfolio companies, 31 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $277.6 million in aggregate exits, sales and repayments. For the year ended December 31, 2021, the Company invested $647.4 million across 46 new portfolio companies, 48 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $461.3 million in aggregate exits, sales and repayments.

Fourth Quarter

For the quarter ended December 31, 2022, the Company invested $45.9 million across 5 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $71.5 million in aggregate exits, sales and repayments. For the quarter ended September 30, 2022, the Company invested $89.8 million across 7 new portfolio companies, 9 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $59.7 million in aggregate exits, sales and repayments.

Results of Operations

Full Year

For the year ended December 31, 2022, investment income totaled $116.7 million, an increase from $94.0 million for the year ended December 31, 2021. The increase was primarily driven by an increase in interest income from investments due to a rise in benchmark rates. Interest income, which includes amortization of upfront fees, increased from $85.7 million for the year ended December 31, 2021 to $108.5 million for the year ended December 31, 2022. Included in interest from investments for the year ended December 31, 2022 and 2021 are $2.4 million and $8.0 million of accelerated accretion of OID related to paydown activity, respectively. Dividend income increased from $7.5 million for the year ended December 31, 2021 to $7.7 million for the year ended December 31, 2022 due to higher distributions from portfolio companies. Other income, which includes consent, waiver, amendment, agency, underwriting and arranger fees associated with our investment activities, decreased from $0.8 million for the year ended December 31, 2021 to $0.5 million for the year ended December 31, 2022 due to lower amendment fees received.

For the years ended December 31, 2022 and 2021, total expenses, including income and excise taxes, totaled $57.0 million and $46.4 million, respectively. Interest and other debt financing costs increased from $19.8 million for the year ended December 31, 2021 to $31.9 million for the year ended December 31, 2022, due to higher weighted average debt outstanding and a higher weighted average cost of debt primarily attributable to the rise in benchmark rates.

Fourth Quarter

For the quarter ended December 31, 2022, investment income totaled $34.6 million, an increase from $29.0 million for the quarter ended September 30, 2022. The increase was primarily driven by an increase in interest income from investments due to a rise in benchmark rates. Interest income, which includes amortization of upfront fees, increased from $27.2 million for the quarter ended September 30, 2022 to $32.8 million for the quarter ended December 31, 2022.

For the quarter ended December 31, 2022, total expenses, including income and excise taxes, totaled $18.5 million, an increase from $13.0 million for the quarter ended September 30, 2022. Interest and other debt financing costs increased from $8.7 million for the quarter ended September 30, 2022 to $11.2 million for the quarter ended December 31, 2022, due to a higher weighted average cost of debt primarily attributable to the rise in benchmark rates.

Liquidity and Capital Resources

As of December 31, 2022, the Company had $17.1 million in cash and cash equivalents and restricted cash and $225.2 million of undrawn capacity on its credit facilities, subject to borrowing base and other limitations. The weighted average interest rate on the Company’s debt outstanding as of December 31, 2022 was 6.23%.

The Company’s debt to equity ratio was 1.08x as of December 31, 2022.

Non-GAAP Financial Measures

On a supplemental basis, the Company is disclosing adjusted net investment income and adjusted net investment income per share, each of which is a financial measure that is calculated and presented on a basis of methodology other than in accordance with U.S. GAAP (“non-GAAP”). Adjusted net investment income represents net investment income, excluding capital gains incentive fees. We use this non-GAAP financial measure internally to analyze and evaluate financial results and performance and believe that this non-GAAP financial measure is useful to investors as an additional tool to evaluate ongoing results and trends without giving effect to capital gains incentive fees. The Company’s investment advisory agreement provides that a capital gains-based incentive fee is determined and paid annually with respect to realized capital gains (but not unrealized capital appreciation) to the extent such realized capital gains exceed realized capital losses and unrealized capital depreciation on a cumulative basis. We believe that adjusted net investment income is a useful performance measure because it reflects the net investment income produced on the Company’s investments during a period without giving effect to any changes in the value of such investments and any related capital gains incentive fees between periods. The presentation of adjusted net investment income is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.

The following table provides an unaudited reconciliation of net investment income (the most comparable U.S. GAAP measure) to adjusted net investment income for the periods presented:

		For the three months ended																														For the years ended December 31,
		December 31, 2022										September 30, 2022 (unaudited)										December 31, 2021										2022										2021
$ in millions, except per share data		Amount					Per Share					Amount					Per Share					Amount					Per Share					Amount					Per Share					Amount					Per Share
GAAP net investment income		$		16.1			$		0.52			$		16.0			$		0.52			$		12.5			$		0.42			$		59.7			$		1.93			$		47.6			$		1.67
Capital gains based incentive fee				(1.1	)				(0.03	)				(3.1	)				(0.10	)				0.2					0.01					(6.3	)				(0.20	)				6.3					0.22
Adjusted net investment income		$		15.0			$		0.49			$		12.9			$		0.42			$		12.7			$		0.43			$		53.4			$		1.73			$		53.9			$		1.89

Conference Call

The Company will host a webcast/conference call on Thursday, February 23, 2023 at 12:00 p.m. (Eastern Time) to discuss its financial results for the quarter and fiscal year ended December 31, 2022. Please visit Crescent BDC’s webcast link located on the Events & Presentations page of the Investor Relations section of Crescent BDC’s website for a slide presentation that complements the earnings conference call.

All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Events & Presentations page of the Investor Resources section of Crescent BDC’s website at www.crescentbdc.com. Please visit the website to test your connection before the webcast. Participants are also invited to access the conference call by dialing the following number:

Toll Free: (888) 396-8049
Conference ID: 56871279

All callers will need to enter the Conference ID followed by the # sign and reference “Crescent BDC” once connected with the operator. An archived replay will be available via a webcast link located on the Investor Relations section of Crescent BDC's website.

Endnotes

Note: Numbers may not sum due to rounding.

1. See “Non-GAAP Financial Measures” above for a description of this non-GAAP measure and a reconciliation from net investment income to adjusted net investment income. The Company's management uses this non-GAAP financial measure internally to analyze and evaluate financial results and performance and believes that this non-GAAP financial measure is useful to investors as an additional tool to evaluate ongoing results and trends for the Company without giving effect to capital gains incentive fees. The presentation of adjusted net investment income is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.
   
   
2. Yield excludes investments on non-accrual status.
   
   
3. Unitranche loans are first lien loans that may extend deeper in a company’s capital structure than traditional first lien debt and may provide for a waterfall of cash flow priority among different lenders in the unitranche loan. In certain instances, the Company may find another lender to provide the “first out” portion of such loan and retain the “last out” portion of such loan, in which case, the “first out” portion of the loan would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last out” portion that the Company would continue to hold. In exchange for the greater risk of loss, the “last out” portion earns a higher interest rate.
   
   

Crescent Capital BDC, Inc.
Consolidated Statements of Assets and Liabilities
(in thousands except share and per share data)

	As of December 31, 2022				As of December 31, 2021
Assets
Investments, at fair value
Non-controlled non-affiliated (cost of $1,235,778 and $1,150,173, respectively)	$	1,208,501			$	1,165,897
Non-controlled affiliated (cost of $42,040 and $41,242, respectively)		43,080				51,701
Controlled (cost of $13,638 and $53,431, respectively)		11,375				52,768
Cash and cash equivalents		6,397				10,069
Restricted cash and cash equivalents		10,670				13,457
Interest and dividend receivable		9,945				6,763
Unrealized appreciation on foreign currency forward contracts		8,154				2,115
Deferred tax assets		91				42
Receivable for investments sold		5				14,871
Other assets		4,660				126
Total assets	$	1,302,878			$	1,317,809
Liabilities
Debt (net of deferred financing costs of $5,380 and $6,897)	$	654,456			$	631,040
Distributions payable		12,664				12,664
Interest and other debt financing costs payable		8,471				5,513
Management fees payable		4,056				3,830
Incentive fees payable		3,112				6,924
Deferred tax liabilities		899				956
Payable for investment purchased		514				-
Directors’ fees payable		151				114
Unrealized depreciation on foreign currency forward contracts		157				631
Accrued expenses and other liabilities		5,857				3,852
Total liabilities	$	690,337			$	665,524
Net assets
Preferred stock, par value $0.001 per share (10,000 shares authorized, zero outstanding, respectively)	$	-			$	-
Common stock, par value $0.001 per share (200,000,000 shares authorized, 30,887,360 shares issued and outstanding, respectively)		31				31
Paid-in capital in excess of par value		675,008				666,162
Accumulated earnings (loss)		(62,498	)			(13,908	)
Total net assets	$	612,541			$	652,285
Total liabilities and net assets	$	1,302,878			$	1,317,809
Net asset value per share	$	19.83			$	21.12

Crescent Capital BDC, Inc.
Consolidated Statements of Operations
(in thousands except share and per share data)

		For the years ended December 31,
		2022				2021				2020
Investment Income:
From non-controlled non-affiliated investments:
Interest income		$	101,751			$	81,371			$	66,078
Paid-in-kind interest			1,564				1,881				2,169
Dividend income			127				1,919				323
Other income			540				791				1,060
From non-controlled affiliated investments:
Interest income			1,625				1,170				1,420
Paid-in-kind interest			2,106				1,235				1,456
Dividend income			5,169				2,414				2,407
Other income			—				3				—
From controlled investments:
Interest income			745				2				—
Paid-in-kind interest			732				—				—
Dividend income			2,358				3,200				2,200
Total investment income			116,717				93,986				77,113
Expenses:
Interest and other debt financing costs			31,880				19,766				15,485
Management fees			16,344				14,118				11,438
Income based incentive fees			11,214				9,849				8,639
Capital gains based incentive fees			(6,324	)			6,324				—
Professional fees			1,302				1,769				1,460
Directors’ fees			524				475				437
Other general and administrative expenses			2,660				2,628				2,544
Total expenses			57,600				54,929				40,003
Management fees waiver			(229	)			(3,302	)			(4,672	)
Income based incentive fees waiver			(538	)			(7,517	)			(8,639	)
Net expenses			56,833				44,110				26,692
Net investment income before taxes			59,884				49,876				50,421
(Benefit) provision for income and excise taxes			155				2,250				541
Net investment income			59,729				47,626				49,880
Net realized and unrealized gains (losses) on investments:
Net realized gain (loss) on:
Non-controlled non-affiliated investments			1,157				3,687				(10,889	)
Non-controlled affiliated investments			7,098				28,810				(4,314	)
Controlled investments			(3,301	)			—				—
Foreign currency transactions			(33	)			311				(83	)
Foreign currency forward contracts			24				(193	)			—
Net change in unrealized appreciation (depreciation) on:
Non-controlled non-affiliated investments and foreign currency translation			(43,818	)			12,535				7,437
Non-controlled affiliated investments			(9,419	)			(10,464	)			19,686
Controlled investments			(1,600	)			602				(1,707	)
Foreign currency forward contracts			6,513				2,116				(1,324	)
Net realized and unrealized gains (losses) on investments			(43,379	)			37,404				8,806
Realized loss on asset acquisition			-				-				(3,825	)
Net realized and unrealized gains (losses) on investments and asset acquisition			(43,379	)			37,404				4,981
Benefit (provision) for taxes on realized gain on investments			(911	)			(1,177	)			46
Benefit (provision) for taxes on unrealized appreciation (depreciation) on investments			105				(220	)			(235	)
Net increase (decrease) in net assets resulting from operations		$	15,544			$	83,633			$	54,672
Per common share data:
Net increase (decrease) in net assets resulting from operations per share (basic and diluted):		$	0.50			$	2.94			$	1.98
Net investment income per share (basic and diluted):		$	1.93			$	1.67			$	1.80
Weighted average shares outstanding (basic and diluted):			30,887,360				28,477,771				27,681,757

About Crescent BDC

Crescent BDC is a business development company that seeks to maximize the total return of its stockholders in the form of current income and capital appreciation by providing capital solutions to middle market companies with sound business fundamentals and strong growth prospects. Crescent BDC utilizes the extensive experience, origination capabilities and disciplined investment process of Crescent. Crescent BDC is externally managed by Crescent Cap Advisors, LLC, a subsidiary of Crescent. Crescent BDC has elected to be regulated as a business development company under the Investment Company Act of 1940. For more information about Crescent BDC, visit www.crescentbdc.com. However, the contents of such website are not and should not be deemed to be incorporated by reference herein.

About Crescent Capital Group

Crescent is a global credit investment manager with over $40 billion of assets under management. For over 30 years, the firm has focused on below investment grade credit through strategies that invest in marketable and privately originated debt securities including senior bank loans, high yield bonds, as well as private senior, unitranche and junior debt securities. Crescent is headquartered in Los Angeles with offices in New York, Boston, Chicago and London with more than 200 employees globally. Crescent is a part of SLC Management, the institutional alternatives and traditional asset management business of Sun Life. For more information about Crescent, visit www.crescentcap.com. However, the contents of such website are not and should not be deemed to be incorporated by reference herein.

Contact:

Dan McMahon
daniel.mcmahon@crescentcap.com
212-364-0149

Forward-Looking Statements

This press release, and other statements that Crescent BDC may make, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to Crescent BDC’s future financial or business performance, strategies or expectations. Forward-looking statements are typically identified by words or phrases such as “trend,” “potential,” “opportunity,” “pipeline,” “believe,” “comfortable,” “expect,” “anticipate,” “current,” “intention,” “estimate,” “position,” “assume,” “outlook,” “continue,” “remain,” “maintain,” “sustain,” “seek,” “achieve,” and similar expressions, or future or conditional verbs such as “will,” “would,” “should,” “could,” “may” or similar expressions.

Crescent BDC cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which may change over time. Forward-looking statements speak only as of the date they are made, and Crescent BDC assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.

In addition to factors previously disclosed in Crescent BDC’s SEC reports and those identified elsewhere in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: (1) our future operating results; (2) our business prospects and the prospects of our portfolio companies; (3) the impact of investments that we expect to make; (4) our contractual arrangements and relationships with third parties; (5) the dependence of our future success on the general economy and its impact on the industries in which we invest; (6) the financial condition of and ability of our current and prospective portfolio companies to achieve their objectives; (7) our expected financings and investments; (8) the adequacy of our cash resources and working capital, including our ability to obtain continued financing on favorable terms; (9) the timing of cash flows, if any, from the operations of our portfolio companies; (10) the impact of increased competition; (11) the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments; (12) potential conflicts of interest in the allocation of opportunities between us and other investment funds managed by our investment adviser or its affiliates; (13) the ability of our investment adviser to attract and retain highly talented professionals; (14) changes in law and policy accompanying the new administration and uncertainty pending any such changes; (15) increased geopolitical unrest, terrorist attacks or acts of war, which may adversely affect the general economy, domestic and local financial and capital markets, or the specific industries of our portfolio companies; (16) changes and volatility in political, economic or industry conditions, the interest rate environment, foreign exchange rates or financial and capital markets; (17) the unfavorable resolution of legal proceedings; and (18) the impact of changes to tax legislation and, generally, our tax position.

Crescent BDC’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC, identifies additional factors that can affect forward-looking statements.

Other Information

The information in this press release is summary information only and should be read in conjunction with Crescent BDC’s annual report on Form 10-K for the year ended December 31, 2022, which Crescent BDC filed with the U.S. Securities and Exchange Commission (the SEC) on February 22, 2023, Crescent BDC’s quarterly reports on Form 10-Q as well as Crescent BDC’s other reports filed with the SEC. A copy of Crescent BDC’s annual report on Form 10-K for the year ended December 31, 2022, Crescent BDC’s quarterly reports on Form 10-Q and Crescent BDC’s other reports filed with the SEC can be found on Crescent BDC’s website at www.crescentbdc.com and the SEC’s website at www.sec.gov.

FAQ

What were Crescent Capital BDC's earnings for the year ended December 31, 2022?

Crescent Capital BDC reported net investment income of $59.7 million or $1.93 per share for 2022.

What is the dividend for Crescent Capital BDC in Q1 2023?

Crescent Capital BDC declared a cash dividend of $0.41 per share for the first quarter of 2023.

How much did Crescent Capital BDC invest in 2022?

The company invested $308 million across 20 new and existing portfolio companies in 2022.

What was the net asset value per share for Crescent Capital BDC at the end of 2022?

The net asset value per share was $19.83 as of December 31, 2022.

What caused the increase in expenses for Crescent Capital BDC in 2022?

Total expenses rose due to increased interest and debt financing costs, totaling $57 million in 2022.